QHA
7 FDA 510(k) clearances · Product code
239 daysmedian time to decision
265 days90th percentile
7clearances measured
FDA profile
- Official device name
- X-Ray Angiographic Imaging Based Coronary Vascular Simulation Software Device
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 892.1600
- Medical specialty
- Radiology
- FDA definition
- X-ray angiographic imaging based coronary vascular simulation software device is a prescription device that provides an image analysis tool to assess blood flow in the coronary vascular system using X-ray angiographic imaging data. X-ray angiographic imaging based coronary vascular simulation software device solves algorithms and yields simulation-based metrics for certain cardiology applications. X-ray angiographic imaging based coronary vascular simulation software device cannot be used alone for clinical decision making and clinical management, and is a tool intended to generate results for use and review by a qualified clinician.
Export predicate table (CSV) Shareable report ◉ Watch exports: 3 free/month · reports & watching: free
| Record | Firm | Date |
|---|---|---|
| X1-FFR (K251355) | Spectrawave, Inc. | 2025-10-17 |
| QFR (3.0) (K243769) | Qfr Solutions BV | 2025-04-04 |
| CAAS Workstation (K232147) | Pie Medical Imaging BV | 2024-04-09 |
| AccuFFRangio Plus (K230303) | ArteryFlow Technology Co., Ltd. | 2023-03-02 |
| AccuICAS (K221711) | ArteryFlow Technology Co., Ltd. | 2023-02-28 |
| AccuFFRangio (K210093) | ArteryFlow Technology Co., Ltd. | 2021-09-10 |
| Qangio XA 3D (K182611) | Medis Medical Imaging Systems BV | 2019-05-30 |
Track QHA automatically
Every clearance here is in the API, with alerts when new ones post.